Scientific article

In vivo study of HCV in mice with chimeric human livers

Published inMethods in molecular biology, vol. 510, p. 383-399
Publication date2009

Estimates of hepatitis C virus infection include 170 million people worldwide, who face increased risk of development of cirrhosis, liver failure, and hepatocellular carcinoma. Standard of care therapy with pegylated interferon and ribavirin is effective in just half of patients, is challenged by substantial treatment-related morbidity, and is prohibitively expensive in most parts of the world. New therapeutics for treatment and prevention are clearly needed. Development of effective therapies has been significantly hampered by difficulties in establishing in vitro and in vivo models of viral replication. This chapter reviews development, validation, and early application of a mouse model with a chimeric human liver.

  • Animals
  • Chimera/virology
  • Disease Models, Animal
  • Hepacivirus/physiology
  • Hepatitis C/pathology/virology
  • Humans
  • Liver/cytology/pathology/virology
  • Mice
  • Reproducibility of Results
  • Virus Cultivation/methods
  • Virus Replication/physiology
Citation (ISO format)
KNETEMAN, Norman M, TOSO, Christian. In vivo study of HCV in mice with chimeric human livers. In: Methods in molecular biology, 2009, vol. 510, p. 383–399. doi: 10.1007/978-1-59745-394-3_29
Main files (1)
Article (Published version)
ISSN of the journal1064-3745

Technical informations

Creation11/05/2013 3:26:00 PM
First validation11/05/2013 3:26:00 PM
Update time03/14/2023 8:45:17 PM
Status update03/14/2023 8:45:16 PM
Last indexation01/16/2024 8:36:38 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack